Utah Medical strikes back
This article was originally published in The Gray Sheet
Executive Summary
HHS has six months from Utah Medical's July 12 bid for reconsideration to honor or deny the firm's request for remedies - including over $7 mil. in damages - at which point the company may pursue legal action, according to CEO Kevin Cornwell. Utah Medical has alleged misconduct on the part of FDA employees during the inspections, review and subsequent enforcement actions that culminated in FDA seeking a permanent sales injunction against the company in Utah federal court. Though Utah Medical emerged victorious in October 2005, it claims the ordeal has done "irreparable harm" to the company's reputation (1"The Gray Sheet" Feb. 20, 2006, p. 13)...
You may also be interested in...
Utah Medical Seeks Reparations From FDA For Alleged FDA Misconduct
Utah Medical is considering whether to file a lawsuit against FDA after the Department of Health & Human Services denied its "administrative claim" seeking payments and other settlement actions based on alleged misconduct by FDA employees
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.